Supachai Sakkhachornphop
Overview
Explore the profile of Supachai Sakkhachornphop including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
24
Citations
173
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sakkhachornphop S, Thongkum W, Sornsuwan K, Juntit O, Jirakunachayapisan K, Kongyai N, et al.
Heliyon
. 2024 Jul;
10(12):e32784.
PMID: 38975074
Early diagnosis of HIV-1 is crucial to minimize transmission, morbidity, and mortality, particularly for neonates with developing immune systems. This study aimed to develop and evaluate a simplified, high-sensitivity assay...
2.
Chawansuntati K, Sakkhachornphop S, Hongjaisee S, Freeouf S, Sripan P, Nusartsang N, et al.
Vaccine X
. 2024 Mar;
18:100475.
PMID: 38549951
Background: In early 2021, the Ministry of Public Health of Thailand announced heterologous regimens for COVID-19 vaccines using CoronaVac as the first dose followed by ChAdOx1 nCoV-19 at 3 weeks...
3.
Hongjaisee S, Chawansuntati K, Sripan P, Rattanathammethee K, Sakkhachornphop S, Chaiwarith R, et al.
Vaccine X
. 2023 May;
14:100305.
PMID: 37155476
Background: In Thailand, early vaccination initiatives for SARS-CoV-2 relied on CoronaVac (Sinovac Life Sciences) and ChAdOx1 (Oxford-AstraZeneca) vaccines. However, the data of immunogenicity of these two vaccines in Thai populations...
4.
Pongsatha S, Tongsong T, Wipasa J, Sakkhachornphop S, Hongjaisee S, Chawansuntati K
Hum Vaccin Immunother
. 2023 Apr;
19(1):2196912.
PMID: 37057690
The objective is to evaluate the effectiveness of placental transfer of maternally derived SARS-CoV-2 IgG antibodies after the vaccination of pregnant women with heterologous CoronaVac-ChAdOx1. Thirty pregnant women were vaccinated...
5.
Juntit O, Sornsuwan K, Wisitponchai T, Lee V, Sakkhachornphop S, Yasamut U, et al.
Int J Mol Sci
. 2023 Mar;
24(6).
PMID: 36982337
Several anti-HIV scaffolds have been proposed as complementary treatments to highly active antiretroviral therapy. Ank1D4, a designed ankyrin repeat protein, formerly demonstrated anti-HIV-1 replication by interfering with HIV-1 Gag polymerization....
6.
Pongsatha S, Chawansuntati K, Sakkhachornphop S, Tongsong T
Vaccines (Basel)
. 2023 Jan;
11(1).
PMID: 36679961
Pregnant women who receive the COVID-19 vaccine develop anti-SARS-CoV-2 antibodies, which can be transferred to the fetus. However, the effectiveness of placental transfer has not been evaluated in twin pregnancy,...
7.
Juntit O, Yasamut U, Sakkhachornphop S, Chupradit K, Thongkum W, Srisawat C, et al.
Asian Pac J Allergy Immunol
. 2022 May;
PMID: 35598193
Background: Assembly and budding in the late-stage of human immunodeficiency virus type 1 (HIV-1) production rely on Gag protein polymerization at the inner leaflet of the plasma membrane. We previously...
8.
Khamphikham P, Sakkhachornphop S, Pongsatha S, Pornprasert S
Hemoglobin
. 2022 May;
46(3):184-186.
PMID: 35543019
Hb Dhonburi (also known as Hb Neapolis) (: c.380T>G) is an unstable hemoglobin (Hb) variant that cannot be detected by high performance liquid chromatography (HPLC) or capillary electrophoresis (CE) in...
9.
Chupradit K, Khamaikawin W, Sakkhachornphop S, Puaninta C, Torbett B, Borwornpinyo S, et al.
Int J Mol Sci
. 2022 Feb;
23(4).
PMID: 35216446
Human hematopoietic stem/progenitor cell (HSPC)-based gene therapy is a promising direction for curing HIV-1-infected individuals. The zinc finger protein (2LTRZFP) designed to target the 2-LTR-circle junction of HIV-1 cDNA was...
10.
Sornsuwan K, Thongkhum W, Pamonsupornwichit T, Carraway T, Soponpong S, Sakkhachornphop S, et al.
Biomolecules
. 2021 Oct;
11(10).
PMID: 34680070
Previously, a designed ankyrin repeat protein, Ank1D4, was generated for intracellular targeting of the HIV-1 capsid domain. The efficiency was satisfactory in interfering with the HIV assembly process. Consequently, improved...